ReviewJournal of cardiovascular translational research2023

The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome.

Dihui Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.